1
|
Gerday A, Lourtie A, Pirard C, Laurent P, Wyns C, Jadoul P, Squifflet JL, Dolmans MM, Van Gossum JP, Hammer F, Luyckx M. Experience With Medical Treatment of Cesarean Scar Ectopic Pregnancy (CSEP) With Local Ultrasound-Guided Injection of Methotrexate. Front Med (Lausanne) 2020; 7:564764. [PMID: 33224958 PMCID: PMC7671087 DOI: 10.3389/fmed.2020.564764] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2020] [Accepted: 09/21/2020] [Indexed: 11/23/2022] Open
Abstract
Objective: Ectopic pregnancy within Cesarean section scars is a rare condition. Late diagnosis carries significant risk of bleeding with poor prognosis for survival. There is no consensus on the management of this type of pregnancy. Historically, our facility offered an intra-muscular injection of methotrexate that resulted in a significant failure rate and later need for surgery. We hypothesized that injecting methotrexate directly into the gestational sac would improve the success rate of the treatment. Patients and Methods: This retrospective, uni-centric study examined nine patients aged between 33 and 42 years (mean age = 36.5 years) with Cesarean scar ectopic pregnancy (CSEP) between 2010 and 2018. CSEP was diagnosed by transvaginal ultrasound at a mean gestational age of 8w0/7. CSEP was treated under general anesthetic by ultrasound-guided methotrexate injection directly into the gestational sac. HCG levels and subsequent childbearing were monitored post-treatment. Results: Half of the patients were asymptomatic at the time of diagnosis. All patients tolerated treatment well and all ectopic pregnancies were successfully removed. HCG levels returned to negative within 3 months without additional medical or surgical intervention. The post-treatment pregnancy rate was 50%. Discussions/Conclusions: Our findings indicate that local ultrasound-guided injection of methotrexate into the gestational sac is a safe and effective therapeutic approach when performed by a trained team on a hemodynamically stable patient in the early stages of CSEP.
Collapse
Affiliation(s)
- Amandine Gerday
- Department of Gynaecology and Andrology, Cliniques Universitaires Saint Luc, Woluwe-Saint-Lambert, Belgium.,Institut de Recherche Clinique Pôle GYNE, Catholic University of Louvain, Brussels, Belgium
| | - Amélie Lourtie
- Department of Gynaecology and Andrology, Cliniques Universitaires Saint Luc, Woluwe-Saint-Lambert, Belgium
| | - Céline Pirard
- Department of Gynaecology and Andrology, Cliniques Universitaires Saint Luc, Woluwe-Saint-Lambert, Belgium
| | - Pascale Laurent
- Department of Gynaecology and Andrology, Cliniques Universitaires Saint Luc, Woluwe-Saint-Lambert, Belgium
| | - Christine Wyns
- Department of Gynaecology and Andrology, Cliniques Universitaires Saint Luc, Woluwe-Saint-Lambert, Belgium.,Institut de Recherche Clinique Pôle ANDRO, Catholic University of Louvain, Brussels, Belgium
| | - Pascale Jadoul
- Department of Gynaecology and Andrology, Cliniques Universitaires Saint Luc, Woluwe-Saint-Lambert, Belgium
| | - Jean-Luc Squifflet
- Department of Gynaecology and Andrology, Cliniques Universitaires Saint Luc, Woluwe-Saint-Lambert, Belgium
| | - Marie-Madeleine Dolmans
- Department of Gynaecology and Andrology, Cliniques Universitaires Saint Luc, Woluwe-Saint-Lambert, Belgium.,Institut de Recherche Clinique Pôle GYNE, Catholic University of Louvain, Brussels, Belgium
| | - Jean-Paul Van Gossum
- Department of Gynaecology and Andrology, Cliniques Universitaires Saint Luc, Woluwe-Saint-Lambert, Belgium.,Department of Gynaecology, Clinique Saint Jean, Brussels, Belgium
| | - Frank Hammer
- Department of Radiology, Cliniques Universitaire Saint Luc, Woluwe-Saint-Lambert, Belgium
| | - Mathieu Luyckx
- Department of Gynaecology and Andrology, Cliniques Universitaires Saint Luc, Woluwe-Saint-Lambert, Belgium.,Institut de Recherche Clinique Pôle GYNE, Catholic University of Louvain, Brussels, Belgium.,Tumor Infiltrating Lymphocytes Group, Institut de Duve, Catholic University of Louvain, Brussels, Belgium
| |
Collapse
|
2
|
Baradwan S, Khan F, Al-Jaroudi D. Successful management of a spontaneous viable monochorionic diamniotic twin pregnancy on cesarean scar with systemic methotrexate: A case report. Medicine (Baltimore) 2018; 97:e12343. [PMID: 30212987 PMCID: PMC6155970 DOI: 10.1097/md.0000000000012343] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Abstract
RATIONALE Cesarean scar twin pregnancy is exceedingly rare and it remains to be a life-threatening condition even in the early weeks of gestation. Because of its rare occurrence, there is no consensus on the treatment modality of cesarean ectopic pregnancy. PATIENT CONCERNS A 41-year-old, woman, gravida 7, para 6, with a history of low transverse cesarean section 2 years back presented with an estimated 6 weeks gestational age and viable spontaneous twin, monochorionic diamniotic gestation. The patient presented to the Emergency Department with complaints of vaginal bleeding and mild lower abdominal pain for 5 days. DIAGNOSES An ultrasound examination was performed demonstrating a single intrauterine gestational sac with 2 viable embryos (monochorionic diamniotic) implanted in the lower uterine segment at the level of the prior cesarean section scar. A diagnosis of viable cesarean scar twin pregnancy was made. INTERVENTIONS A 2 doses of 50 mg/m methotrexate (MTX) was given intramuscularly. The response to the treatment was monitored by serial beta-human chorionic gonadotropin (β-hCG) and ultrasound. OUTCOMES Patient was followed up with β-hCG weekly levels which became 0 after 68 days of treatment. During the follow-up, the patient was asymptomatic, no side effects of MTX were noticed. LESSONS We reported a rare case of viable monochorionic diamniotic twin pregnancy on a cesarean scar that was successfully treated with systemic MTX without any additional therapy. Additionally, the decline of β-hCG in twin ectopic cesarean scar pregnancy appears to be similar to a singleton ectopic pregnancy.
Collapse
Affiliation(s)
| | | | - Dania Al-Jaroudi
- Reproductive Endocrine and Infertility Medicine Department, King Fahad Medical City, Riyadh, Saudi Arabia
| |
Collapse
|
3
|
Papillon-Smith J, Sobel ML, Niles KM, Solnik MJ, Murji A. Surgical Management Algorithm for Caesarean Scar Pregnancy. JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA 2017; 39:619-626. [DOI: 10.1016/j.jogc.2017.01.027] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2016] [Revised: 01/28/2017] [Accepted: 01/29/2017] [Indexed: 11/17/2022]
|
4
|
Bodur S, Özdamar Ö, Kılıç S, Gün İ. The efficacy of the systemic methotrexate treatment in caesarean scar ectopic pregnancy: A quantitative review of English literature. J OBSTET GYNAECOL 2014; 35:290-6. [DOI: 10.3109/01443615.2014.954101] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
5
|
Wang HY, Zhang J, Li YN, Wei W, Zhang DW, Lu YQ, Zhang HF. Laparoscopic management or laparoscopy combined with transvaginal management of type II cesarean scar pregnancy. JSLS 2013; 17:263-72. [PMID: 23925020 PMCID: PMC3771793 DOI: 10.4293/108680813x13654754535197] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Laparoscopy combined with transvaginal management appeared to result in less bleeding, shorter operative times, and a lower rate of complication in patients with uterine wound rupture and dense adhesions. Objective: To evaluate the clinical effectiveness of laparoscopic management of cesarean scar pregnancy (CSP) by deep implantation. Background: A pregnancy implanting within the scar from a previous cesarean delivery is a rare condition of ectopic pregnancy. There are two different types of CSPs. Type I is caused by implantation of the amniotic sac on the scar with progression toward either the cervicoisthmic space or the uterine cavity. Type II (CSP-II) is caused by deep implantation into a previous CS defect with infiltrating growth into the uterine myometrium and bulging from the uterine serosal surface, which may result in uterine rupture and severe bleeding during the first trimester of pregnancy. Thus, timely management with an early and accurate diagnosis of CSP-II is important. However, laparoscopic management in CSP-II has not yet been evaluated. Methods: Eleven patients with CSP-II underwent conservative laparoscopic surgery or laparoscopy combined with transvaginal bilateral uterine artery ligation and resection of the scar with gestational tissue and wound repair to preserve the uterus from March 2008 to November 2011. Patients with CSP-II were diagnosed using color Doppler sonography, and the diagnosis was confirmed by laparoscopy. The operation time, the blood loss during surgery, the levels of β-human chorionic gonadotropin (β-hCG) before surgery, the time taken for serum β-hCG levels to return to <100 mIU/mL postoperatively, and the time for the uterine body to revert to its original state were retrospectively analyzed. Results: All 11 operations were successfully performed using laparoscopy with preservation of the uterus. One patient underwent a dilation and curettage after laparoscopic bilateral uterine artery ligation. Eight patients were treated solely by laparoscopic bilateral uterine artery ligation and resection of the scar with gestational tissue and wound repair. The remaining two patients underwent laparoscopic bilateral uterine artery ligation and transvaginal resection of the CS with gestational tissue and wound repair because of dense adhesions and heavy bleeding. The average operation time was 85.5 (±17.5) minutes, and the blood loss was 250.0 (±221.4) mL. The blood serum level of β-hCG returned to <100 mIU/mL in 16.4 (±5.3) days postoperatively. Among the 10 patients who underwent resection of CS and wound repair, the time for the uterus to revert to its original state (judged by ultrasonography) was 10.8 (±3.0) days postoperatively. Conclusions: Laparoscopy can remove ectopic gestational tissue and allow subsequent wound repair, as well as provide diagnostic confirmation. Being a minimally invasive procedure, laparoscopic or laparoscopy combined with transvaginal bilateral uterine artery ligation and resection of the scar with gestational tissue and wound repair can become an effective alternative for the treatment of CSP-II.
Collapse
Affiliation(s)
- Huan-Ying Wang
- Department of Obstetrics and Gynecology, Capital Medical University, Beijing, China
| | | | | | | | | | | | | |
Collapse
|
6
|
Zhang XB, Zhong YC, Chi JC, Shen JL, Qiu XX, Xu JR, Zhao AM, Di W. Caesarean Scar Pregnancy: Treatment with Bilateral Uterine Artery Chemoembolization Combined with Dilation and Curettage. J Int Med Res 2012. [PMID: 23206476 DOI: 10.1177/030006051204000533] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
Objective: This study investigated bilateral uterine artery chemo -embolization (BUACE) combined with dilation and curettage (D&C) in caesarean scar pregnancy (CSP). Methods: Nineteen women with CSP were referred for interventional radiology. In 13 patients, BUACE was performed before D&C, following a diagnosis of CSP. A further six patients received BUACE for massive vaginal bleeding after D&C for inevitable miscarriage; the diagnosis of CSP was subsequently confirmed ultrasonographically. BUACE of the uterine arteries was performed using gelfoam particles following intra-arterial infusion of 100 mg/m2 methotrexate. Results: BUACE was technically successful and immediate haemostasis was achieved in all patients. Blood loss was significantly greater during D&C undertaken before BUACE compared with D&C after BUACE, but this bleeding was controlled by BUACE. No patient required further surgical intervention and there were no severe complications. The gestational sac and placenta could no longer be detected ultrasonographically and the menstrual cycle returned to normal 2 - 3 months after treatment in all patients. Conclusions: BUACE followed by D&C seems to be a safe and effective treatment for CSP and should be considered as a treatment of choice.
Collapse
Affiliation(s)
- X-B Zhang
- Department of Interventional Radiology, Renji Hospital, Shanghai JiaoTong University Medical School, Shanghai, China
| | - Y-C Zhong
- Department of Obstetrics and Gynaecology, Renji Hospital, Shanghai JiaoTong University Medical School, Shanghai, China
| | - J-C Chi
- Department of Interventional Radiology, Renji Hospital, Shanghai JiaoTong University Medical School, Shanghai, China
| | - J-L Shen
- Department of Interventional Radiology, Renji Hospital, Shanghai JiaoTong University Medical School, Shanghai, China
| | - X-X Qiu
- Department of Interventional Radiology, Renji Hospital, Shanghai JiaoTong University Medical School, Shanghai, China
| | - J-R Xu
- Department of Interventional Radiology, Renji Hospital, Shanghai JiaoTong University Medical School, Shanghai, China
| | - A-M Zhao
- Department of Obstetrics and Gynaecology, Renji Hospital, Shanghai JiaoTong University Medical School, Shanghai, China
| | - W Di
- Department of Obstetrics and Gynaecology, Renji Hospital, Shanghai JiaoTong University Medical School, Shanghai, China
| |
Collapse
|
7
|
Timor-Tritsch IE, Monteagudo A. Unforeseen consequences of the increasing rate of cesarean deliveries: early placenta accreta and cesarean scar pregnancy. A review. Am J Obstet Gynecol 2012; 207:14-29. [PMID: 22516620 DOI: 10.1016/j.ajog.2012.03.007] [Citation(s) in RCA: 363] [Impact Index Per Article: 30.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2011] [Revised: 01/28/2012] [Accepted: 03/09/2012] [Indexed: 11/29/2022]
Abstract
This review concentrates on 2 consequences of cesarean deliveries that may occur in a subsequent pregnancy. They are the pathologically adherent placenta and the cesarean scar pregnancy. We explored their clinical and diagnostic as well as therapeutic similarities. We reviewed the literature concerning the occurrence of early placenta accreta and cesarean section scar pregnancy. The review resulted in several conclusions: (1) the diagnosis of placenta accreta and cesarean scar pregnancy is difficult; (2) transvaginal ultrasound seems to be the best diagnostic tool to establish the diagnosis; (3) an early and correct diagnosis may prevent some of their complications; (4) curettage and systemic methotrexate therapy and embolization as single treatments should be avoided if possible; and (5) in the case of cesarean scar pregnancy, local methotrexate- and hysteroscopic-directed procedures had the lowest complication rates.
Collapse
Affiliation(s)
- Ilan E Timor-Tritsch
- Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY 10016, USA.
| | | |
Collapse
|
8
|
Timor-Tritsch IE, Monteagudo A, Santos R, Tsymbal T, Pineda G, Arslan AA. The diagnosis, treatment, and follow-up of cesarean scar pregnancy. Am J Obstet Gynecol 2012; 207:44.e1-13. [PMID: 22607667 DOI: 10.1016/j.ajog.2012.04.018] [Citation(s) in RCA: 178] [Impact Index Per Article: 14.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2011] [Revised: 03/16/2012] [Accepted: 04/09/2012] [Indexed: 10/28/2022]
Abstract
OBJECTIVE The diagnosis and treatment of cesarean scar pregnancy (CSP) is challenging. The objective of this study was to evaluate the diagnostic method, treatments, and long-term follow-up of CSP. STUDY DESIGN This is a retrospective case series of 26 patients between 6-14 postmenstrual weeks suspected to have CSP who were referred for diagnosis and treatment. The diagnosis was confirmed with transvaginal ultrasound. In 19 of the 26 patients the gestational sac was injected with 50 mg of methotrexate: 25 mg into the area of the embryo/fetus and 25 mg into the placental area; and an additional 25 mg was administered intramuscularly. Serial serum human chorionic gonadotropin determinations were obtained. Gestational sac volumes and vascularization were assessed by 3-dimensional ultrasound and used to monitor resolution of the injected site and outcome. RESULTS The 19 treated pregnancies were followed for 24-177 days. No complications were observed. After the treatment, typically, there was an initial increase in the human chorionic gonadotropin serum concentrations as well as in the volume of the gestational sac and their vascularization. After a variable time period mentioned elsewhere the values decreased, as expected. CONCLUSION Combined intramuscular and intragestational methotrexate injection treatment was successful in treating these CSP.
Collapse
|
9
|
Jiang T, Liu G, Huang L, Ma H, Zhang S. Methotrexate therapy followed by suction curettage followed by Foley tamponade for caesarean scar pregnancy. Eur J Obstet Gynecol Reprod Biol 2011; 156:209-11. [PMID: 21392878 DOI: 10.1016/j.ejogrb.2011.01.016] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2010] [Revised: 12/26/2010] [Accepted: 01/23/2011] [Indexed: 11/18/2022]
Abstract
OBJECTIVES Caesarean scar pregnancy (CSP) is a very rare and dangerous form of pregnancy because of the increased risk of rupture and excessive hemorrhage. There is currently no consensus on the treatment. We studied if methotrexate (MTX) therapy followed by suction curettage followed by Foley tamponade was a viable treatment for patients with CSP. STUDY DESIGN Forty-five patients with CSP in our hospital received a single dose of 50mg/m(2) MTX by intramuscular injection. If gestational cardiac activity was seen on transvaginal ultrasound, local injection of MTX was given. After 7 days, suction curettage was performed to remove the retained products of conception and blood clot (CSP mass) under transabdominal sonography (TAS) guidance. After the suction curettage, a Foley catheter balloon was placed into the isthmic portion of cervix. RESULTS Forty-two subjects were successfully treated and 3 subjects failed treatment. The mean estimated blood loss of all 45 patients was 706.89 ± 642.08 (100-3000)ml. The resolution time of the serum β-hCG was 20.62 ± 5.41 (9-33) days. The time to CSP mass disappearance was 12.57 ± 4.37 (8-25) days. CONCLUSIONS MTX administration followed by suction curettage followed by Foley tamponade was an effective treatment for caesarean scar pregnancy.
Collapse
Affiliation(s)
- Tao Jiang
- Department of Gynecology and Obstetrics, Shengjing Hospital of China Medical University, No. 36, Sanhao Street, Heping District, Shenyang, Liaoning Province 110004, China.
| | | | | | | | | |
Collapse
|